Tanja is the CEO of Debiopharm Innovation Fund, the digital health investment arm of Debiopharm located in Lausanne, Switzerland.
— Sachs Associates (@SachsAssociates) January 12, 2022
e-Meet Tanja at #Sachs_EHTF
More info @ https://t.co/jbnxjW3r5f@DebiopharmFund pic.twitter.com/Eb9rqHjXON
